Cambridge Cancer Genomics Company
Cambridge Cancer Genomics develops precision oncology solutions to transform the way cancer patients are treated.
Technology:
Biotechnology, Health Care, Health Diagnostics, Medical
Industry:
AI in Pharma, Early Drug Development
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Founded Date:
2016-01-01
Employees Number:
11-50
Funding Status:
M&A
Investors Number:
10
Total Funding:
8500000
Estimated Revenue:
Less than $1M
Last Funding Date:
2018-12-31
Last Funding Type:
Seed
Register and Claim Ownership